Literature DB >> 20442337

Quality initiatives: strategies for anticipating and reducing complications and treatment failures in hepatic radiofrequency ablation.

Mishal Mendiratta-Lala1, Olga Rachel Brook, Brian D Midkiff, Darren D Brennan, Eavan Thornton, Salomao Faintuch, Robert Glenn Sheiman, S Nahum Goldberg.   

Abstract

Radiofrequency (RF) ablation is one of several local treatment strategies that can be used for the destruction of a variety of primary and secondary liver tumors. As experience with RF ablation grows, it becomes increasingly evident that successful ablation requires meticulous technique. In addition, knowledge of potential complications is critical for both the interventionalist and the radiologist, whose postablation interpretation can facilitate identification of complications and treatment failures. Hepatic RF ablation offers significant advantages in that it is less invasive than surgery and carries a low risk of major complications. Successful prevention of complications and treatment failures begins at initial consultation and continues with preablation evaluation of specific patient factors such as coagulation profiles, use of medications, and risk factors for infection. Other predisposing factors include background liver cirrhosis, prior hepatectomy, and portal hypertension. During ablation, careful attention must be given to tumor size, number, and location. For large or multiple ablations, separate ablation sessions can help reduce the prevalence of postablation syndrome, and clustered electrodes and multiple overlapping treatment zones may be used to reduce the risk of treatment failure. It is critical to reevaluate tumors during ablation to determine the best approach and to compensate for changes in size and relative location due to patient positioning. With use of these strategies, hepatic RF ablation can be performed with greater safety, better patient tolerance, and a reduced risk of complications and treatment failures.

Entities:  

Mesh:

Year:  2010        PMID: 20442337     DOI: 10.1148/rg.304095202

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  6 in total

1.  Role of ablation: should it be used as primary therapy for early-stage hepatocellular carcinoma?

Authors:  Maurizio Pompili; Giampiero Francica
Journal:  Hepat Oncol       Date:  2015-11-06

2.  Comparison between different thickness umbrella-shaped expandable radiofrequency electrodes (SuperSlim and CoAccess): Experimental and clinical study.

Authors:  Masahiko Koda; Shiho Tokunaga; Tomomitsu Matono; Takaaki Sugihara; Takakazu Nagahara; Yoshikazu Murawaki
Journal:  Exp Ther Med       Date:  2011-09-01       Impact factor: 2.447

Review 3.  Complications of radiofrequency ablation of hepatic tumors: Frequency and risk factors.

Authors:  Alexandre Zanchenko Fonseca; Stephanie Santin; Luiz Guilherme Lisboa Gomes; Jaques Waisberg; Marcelo Augusto Fontenelle Ribeiro
Journal:  World J Hepatol       Date:  2014-03-27

4.  Laparoscopic repair of a diaphragmatic hernia associated with radiofrequency ablation for hepatocellular carcinoma: lessons from a case and the review of the literature.

Authors:  Ryohei Nomura; Hiromi Tokumura; Makoto Furihata
Journal:  Int Surg       Date:  2014 Jul-Aug

5.  Efficacy and safety of computed tomography-guided microwave ablation with fine needle-assisted puncture positioning technique for hepatocellular carcinoma.

Authors:  Ming-Zhi Hao; Yu-Bin Hu; Qi-Zhong Chen; Zhang-Xian Chen; Hai-Lan Lin
Journal:  World J Gastrointest Oncol       Date:  2022-09-15

Review 6.  Ultrasound-Guided Percutaneous Radiofrequency Ablation of Liver Tumors: How We Do It Safely and Completely.

Authors:  Jin Woong Kim; Sang Soo Shin; Suk Hee Heo; Jun Hyung Hong; Hyo Soon Lim; Hyun Ju Seon; Young Hoe Hur; Chang Hwan Park; Yong Yeon Jeong; Heoung Keun Kang
Journal:  Korean J Radiol       Date:  2015-10-26       Impact factor: 3.500

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.